Listar por autor "Probst, C."
Mostrando ítems 1-4 de 4
-
DIAGNOSTIC AND CLINICAL APPLICATION OF A NEW LINE IMMUNOASSAY THAT SIMULTANEOUSLY DETECTS THE MULTIPLE NUCLEAR DOT SPECIFIC ANTIGENS IN PRIMARY BILIARY CIRRHOSIS
Mytilinaiou, M.; Meyer, W.; Janssen, A.; Pavlides, P.; Probst, C.; Gatselis, N. K.; Komorowski, L.; Schlumberger, A.; Vergani, D.; Bogdanos, D. P. (2009) -
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis
Mytilinaiou, M. G.; Meyer, W.; Scheper, T.; Rigopoulou, E. I.; Probst, C.; Koutsoumpas, A. L.; Abeles, D.; Burroughs, A. K.; Komorowski, L.; Vergani, D.; Bogdanos, D. P. (2012)Background: The lack of an immunoassay that detects antibodies to promyelocytic leukaemia (PML) protein, the primary biliary cirrhosis (PBC)-specific multiple nuclear dot (MND) antigen, has prompted us to develop a line ... -
F1F0-ATPASE AS AN AUTOANTIGENIC TARGET IN PATIENTS WITH ANTI-MITOCHONDRIAL ANTIBODY NEGATIVE PRIMARY BILIARY CIRRHOSIS
Mytilinaiou, M. G.; Komorowski, L.; Rigopoulou, E. I.; Janssen, A.; Probst, C.; Vergani, D.; Bogdanos, D. P. (2010) -
Longitudinal determination of IgA isotype-specific antibodies targeting the major recombinant mitochondrial antigens in patients with primary biliary cirrhosis
Spyrou, E.; Komorowski, L.; Probst, C.; Rigopoulou, E. I.; Bogdanos, D. P.; Dalekos, G. N. (2013)